Professional Summary

Dr. Doodes is highly regarded and award winning dentist here in the Chicago metropolitan area. He is a member of  the Chicago Dental Society, the Illinois State Dental Society, the American Dental Association, and the American Association of Dental Research.

Dr. Doodes and the dedicated Park Blvd Dentistry team understand the importance of excellent dental care and oral hygiene, and they are committed to providing you with the best treatment in a pleasant, professional environment.  Dr. Doodes strives to keep up with the ever-changing advances in dental science and technology so that he can provide each of his patients with the best care that today’s dentistry can offer.  As a doctor, he recognizes that his patients are each unique individuals who have placed a great deal of trust in himself and the Park Blvd Dentistry team, which is just one of many reasons why he values each and every patient relationship.  Dr. Doodes goal is to be able to help his patients attain and maintain the beautiful smiles they have always dreamed of having.

AWARDS

• The Pierre Fauchard Academy Award for Leadership, Clinical & Academic Excellence, 2012
• UIC Clinic and Research Day 2009 – Omicron Kappa Upsilon - Best Basic Research Award UIC Clinic and Research Day 2009 – Hinman Award – Best Predoctoral Basic Science Award
• Runner-up for Best Basic Science Award at Hinman Conference, Memphis, TN 2009
• Midwest Dental Research Conference – Oral and Poster presentation - 2009
• Rush Research Forum Sigma Xi Award for Outstanding Research Poster and Presentation 2004, 2005, 2006 – Graduate College, 3rd, 2nd and 1st place, respectively.

PROFESSIONAL PUBLICATION & ARTICLES

• IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. Doodes PD, et al., J Immunol. 2010 Feb 1;184(3):1552-9.
• CCR5 Required for Resolution Not Initiation of Inflammation in PGIA. Doodes P.D, et al..
• Arthritis and Rheumatism 2009.
• Development of proteoglycan-induced arthritis is independent of IL-17. Doodes PD, et al., J Immunol. 2010 Feb 1;184(3):1552-9.
• Pathways for interleukin-1-driven arthritis. Doodes P, Finnegan A. Arthritis and Rheumatism 2008 Nov;58(11):3283-5.
• Development of proteoglycan-induced arthritis is independent of IL-17. Doodes P, Cao Y, Hamel KM, Wang Y, Farkas B, Iwakura Y, Finnegan A. J Immunol. 2008 Jul 1;181(1):329-37
• Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity. Hamel K, Doodes P, Cao Y, Wang Y, Martinson J, Dunn R, Kehry MR, Farkas B, Finnegan A. J Immunol. 2008 Apr 1;180(7):4994- 5003.
• IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. Cao Y, Doodes P, Glant TT, Finnegan A. J Immunol. 2008 Jan 15;180(2):922-30.
• Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. O'Neill SK, Cao Y, Hamel KM , Doodes P, Hutas G, Finnegan A. J Immunol. 2007 Oct 15;179(8):5109-16.

ACADEMIC QUALIFICATIONS

• DDS Dental Degree from University of Illinois College of Dentistry
• Ph.D Immunology and Microbiology from Rush University Medical Center
• BS    Biological & Medicinal Chemistry from University of East Anglia, UK.